Development and Research How (not) to waste a billion dollars (on your clinical trial) — with Meri Beckwith
15 snips
May 20, 2025 
Meri Beckwith, Founder of Lindus Health, shares her unique perspective as a clinical trial patient and venture capitalist. She reveals why clinical trials lag behind in technology adoption. Meri discusses unexpected factors, like a flooded supply closet, that can lead to billion-dollar failures. She highlights the need for innovative patient recruitment and streamlined operations to enhance trial integrity. Lastly, she critiques traditional practices and advocates for adaptive methodologies to revolutionize drug development and improve patient engagement.
AI Snips
Chapters
Transcript
Episode notes
Poor Tech in COVID Trials
- Meri Beckwith volunteered for COVID vaccine trials and found the signup process cumbersome and outdated.
- He experienced technical glitches and poor participant support despite the trials' high value per participant.
Operational Errors Waste Trials
- Around 10% of phase two or three clinical trials fail due to operational errors, not drug efficacy.
- Poor execution wastes huge value and can invalidate statistically significant results.
Fragmented Trial Data Systems
- Clinical trial data is scattered across multiple systems without consistent standards.
- This fragmented data capture slows analysis and hinders insights that could improve trials.